245 related articles for article (PubMed ID: 20437471)
41. Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates.
Qi H; Ratnam M
Cancer Res; 2006 Jun; 66(11):5875-82. PubMed ID: 16740727
[TBL] [Abstract][Full Text] [Related]
42. Epigenetic modifications in valproic acid-induced teratogenesis.
Tung EW; Winn LM
Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
[TBL] [Abstract][Full Text] [Related]
43. Interactive competition between homologous recombination and non-homologous end joining.
Allen C; Halbrook J; Nickoloff JA
Mol Cancer Res; 2003 Oct; 1(12):913-20. PubMed ID: 14573792
[TBL] [Abstract][Full Text] [Related]
44. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.
Walmod PS; Skladchikova G; Kawa A; Berezin V; Bock E
Cell Motil Cytoskeleton; 1999; 42(3):241-55. PubMed ID: 10098937
[TBL] [Abstract][Full Text] [Related]
45. Carbamazepine is an inhibitor of histone deacetylases.
Beutler AS; Li S; Nicol R; Walsh MJ
Life Sci; 2005 May; 76(26):3107-15. PubMed ID: 15850602
[TBL] [Abstract][Full Text] [Related]
46. HDAC inhibitors: roles of DNA damage and repair.
Robert C; Rassool FV
Adv Cancer Res; 2012; 116():87-129. PubMed ID: 23088869
[TBL] [Abstract][Full Text] [Related]
47. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
Fujiki R; Sato A; Fujitani M; Yamashita T
Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
[TBL] [Abstract][Full Text] [Related]
48. Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells.
Lamparter CL; Winn LM
Toxicol Appl Pharmacol; 2016 Sep; 306():69-78. PubMed ID: 27381264
[TBL] [Abstract][Full Text] [Related]
49. Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line.
Balasubramanian D; Deng AX; Doudney K; Hampton MB; Kennedy MA
Neuropharmacology; 2015 Dec; 99():79-88. PubMed ID: 26151765
[TBL] [Abstract][Full Text] [Related]
50. DNA double-strand breaks and DNA recombination in benzene metabolite-induced genotoxicity.
Tung EW; Philbrook NA; Macdonald KD; Winn LM
Toxicol Sci; 2012 Apr; 126(2):569-77. PubMed ID: 22247006
[TBL] [Abstract][Full Text] [Related]
51. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
Gurvich N; Berman MG; Wittner BS; Gentleman RC; Klein PS; Green JB
FASEB J; 2005 Jul; 19(9):1166-8. PubMed ID: 15901671
[TBL] [Abstract][Full Text] [Related]
52. Homologous recombination initiated by benzene metabolites: a potential role of oxidative stress.
Winn LM
Toxicol Sci; 2003 Mar; 72(1):143-9. PubMed ID: 12604843
[TBL] [Abstract][Full Text] [Related]
53. The R438W polymorphism of human DNA polymerase lambda triggers cellular sensitivity to camptothecin by compromising the homologous recombination repair pathway.
Capp JP; Boudsocq F; Bergoglio V; Trouche D; Cazaux C; Blanco L; Hoffmann JS; Canitrot Y
Carcinogenesis; 2010 Oct; 31(10):1742-7. PubMed ID: 20693240
[TBL] [Abstract][Full Text] [Related]
54. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
Khan S; Jena G; Tikoo K
Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
[TBL] [Abstract][Full Text] [Related]
55. High content analysis of histone acetylation in human cells and tissues.
Narayan PJ; Dragunow M
J Neurosci Methods; 2010 Oct; 193(1):54-61. PubMed ID: 20817035
[TBL] [Abstract][Full Text] [Related]
56. Protective Effects of Valproic Acid, a Histone Deacetylase Inhibitor, against Hyperoxic Lung Injury in a Neonatal Rat Model.
Cetinkaya M; Cansev M; Cekmez F; Tayman C; Canpolat FE; Kafa IM; Yaylagul EO; Kramer BW; Sarici SU
PLoS One; 2015; 10(5):e0126028. PubMed ID: 25938838
[TBL] [Abstract][Full Text] [Related]
57. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy.
Botrugno OA; Robert T; Vanoli F; Foiani M; Minucci S
Clin Cancer Res; 2012 May; 18(9):2436-42. PubMed ID: 22512979
[TBL] [Abstract][Full Text] [Related]
58. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells.
Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M
Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435
[TBL] [Abstract][Full Text] [Related]
59. Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice.
Jing L; Luo J; Zhang M; Qin WJ; Li YL; Liu Q; Wang YT; Lawrence AJ; Liang JH
Neurosci Lett; 2011 Apr; 494(2):169-73. PubMed ID: 21396430
[TBL] [Abstract][Full Text] [Related]
60. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
Leng Y; Chuang DM
J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
